{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:14:20Z","timestamp":1789416860169,"version":"build-2803163510"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Osteosarcoma remains a therapeutically challenging malignancy with durable responses limited by frequent treatment resistance. Although immune activity is detectable in many tumors, immunotherapy and combination strategies show limited clinical benefit, indicating immune dysfunction extends beyond tumor-intrinsic mechanisms. Growing evidence identifies immune exclusion as a key immunological barrier in osteosarcoma, characterized by spatial and functional segregation of immune cells from malignant areas despite their presence in the tumor microenvironment. Here, we use immune exclusion as a working term to describe contexts in which immune cells are present but have limited effective access to, or engagement with, malignant cells\u2014distinct from immune desert (near-absence of infiltrates) and immune-cold states (weak effector activation despite some infiltration). In this mini-review, we focus on immune exclusion as a context-dependent immunological driver of treatment resistance in osteosarcoma. We integrate insights from single-cell sequencing, spatial profiling, and multi-omics studies to characterize the immunological features of immune exclusion, highlight bone-associated structural and regulatory factors, and explore how exclusion creates selective pressure leading to therapeutic failure. Emerging data indicate that immune exclusion represents a coordinated program involving tumor, stromal, and immune elements, resulting in impaired immune\u2013tumor interaction and ineffective clearance. We discuss the translational implications, stressing immune-context modulation as essential for re-sensitization and noting that many current single-cell and spatial datasets remain limited in sample size, sampling sites, and treatment background. Framing resistance through immune exclusion offers an immune-centric framework for understanding and overcoming treatment resistance in osteosarcoma.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1802194","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:03:42Z","timestamp":1774368222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Immune exclusion as a recurrent immune-escape state driving treatment resistance in osteosarcoma: insights from single-cell, spatial, and multi-omics studies"],"prefix":"10.3389","volume":"17","author":[{"given":"Yunxia","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, The Fourth Affiliated Hospital of Southwest Medical University","place":["Meishan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyao","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wen","sequence":"additional","affiliation":[{"name":"Health Management Center, The Fourth Affiliated Hospital of Southwest Medical University","place":["Meishan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjie","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Medical Equipment, The Fourth Affiliated Hospital of Southwest Medical University","place":["Meishan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medical Equipment, The Fourth Affiliated Hospital of Southwest Medical University","place":["Meishan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Feng","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The Affiliated Hospital of Southwest Medical University","place":["Luzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shili","family":"Liu","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The Fourth Affiliated Hospital of Southwest Medical University","place":["Meishan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, The Fourth Affiliated Hospital of Southwest Medical University","place":["Meishan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/cancers13081757","article-title":"Systematic review of recurrent osteosarcoma systemic therapy","volume":"13","author":"Gazouli","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1394284","article-title":"Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms","volume":"15","author":"Orrapin","year":"2024","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1640645","article-title":"Deciphering spatially confined immune evasion niches in osteosarcoma with 3-D spatial transcriptomics: a literature review","volume":"15","author":"Qiu","year":"2025","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1084887","article-title":"Towards a consensus definition of immune exclusion in cancer","volume":"14","author":"Tiwari","year":"2023","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s12672-025-02208-9","article-title":"Systemic strategies for osteosarcoma: advances and future directions","volume":"16","author":"Morya","year":"2025","journal-title":"Discov Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006773","article-title":"Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop","volume":"11","author":"Clifton","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1445555","article-title":"Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1135456","article-title":"Cancer immune exclusion: breaking the barricade for a successful immunotherapy","volume":"13","author":"Bruni","year":"2023","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006991","article-title":"Cell membrane-anchored and tumor-targeted IL-12 T-cell therapy destroys cancer-associated fibroblasts and disrupts extracellular matrix in heterogenous osteosarcoma xenograft models","volume":"12","author":"Hu","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1724768","article-title":"Oncolytic virus therapy for osteosarcoma: mechanisms, opportunities, and challenges","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14398","article-title":"Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma","volume":"111","author":"Deng","year":"2020","journal-title":"Cancer Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e23601","DOI":"10.1016\/j.heliyon.2023.e23601","article-title":"Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41413-022-00237-6","article-title":"Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma","volume":"11","author":"Liu","year":"2023","journal-title":"Bone Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12672-025-04315-z","article-title":"Targeting the osteosarcoma immune microenvironment for improved immunotherapy and translational applications","volume":"17","author":"Cai","year":"2025","journal-title":"Discov Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S485672","article-title":"Myeloid cells in the immunosuppressive microenvironment as immunotargets in osteosarcoma","volume":"14","author":"Sholevar","year":"2025","journal-title":"Immunotarg Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3892\/or.2026.9050","article-title":"Tumor microenvironment in bone sarcomas: Implications for immunotherapy and emerging therapeutic vulnerabilities (Review)","volume":"55","author":"Li","year":"2026","journal-title":"Oncol Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/s41467-020-20059-6","article-title":"Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-024-00949-3","article-title":"Exploring the impact of PDGFD in osteosarcoma metastasis through single-cell sequencing analysis","volume":"47","author":"Huang","year":"2024","journal-title":"Cell Oncol (Dordr)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3390\/cancers17132117","article-title":"Immunosuppressive tumor microenvironment of osteosarcoma","volume":"17","author":"Taylor","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12916-024-03319-w","article-title":"Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcoma","volume":"22","author":"Liu","year":"2024","journal-title":"BMC Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-3723","article-title":"Spatial profiling identifies regionally distinct microenvironments and targetable immunosuppressive mechanisms in pediatric osteosarcoma pulmonary metastases","volume":"85","author":"Eigenbrood","year":"2025","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13046-020-01685-w","article-title":"The role of extracelluar matrix in osteosarcoma progression and metastasis","volume":"39","author":"Cui","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.709210","article-title":"Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7150\/thno.73714","article-title":"Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma","volume":"12","author":"Huang","year":"2022","journal-title":"Theranostics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100604","DOI":"10.1016\/j.jbo.2024.100604","article-title":"Single-cell transcriptional profiling in osteosarcoma and the effect of neoadjuvant chemotherapy on the tumor microenvironment","volume":"46","author":"He","year":"2024","journal-title":"J Bone Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1344272","article-title":"Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors","volume":"15","author":"Ouyang","year":"2024","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1703449","DOI":"10.1080\/2162402X.2019.1703449","article-title":"Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology","volume":"9","author":"Vanmeerbeek","year":"2020","journal-title":"Oncoimmunology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001772","article-title":"Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes","volume":"9","author":"Ligon","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.32607\/actanaturae.11523","article-title":"Immunogenic cell death in cancer therapy","volume":"14","author":"Troitskaya","year":"2022","journal-title":"Acta Naturae"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3390\/ijms26041613","article-title":"Immunogenic cell death inducers in cancer immunotherapy to turn cold tumors into hot tumors","volume":"26","author":"Lucarini","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","article-title":"Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment","volume":"12","author":"Yang","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12943-024-01973-5","article-title":"The senescence journey in cancer immunoediting","volume":"23","author":"Zingoni","year":"2024","journal-title":"Mol Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.21203\/rs.3.rs-3232360\/v1","article-title":"Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-na\u00efve primary osteosarcoma in dogs","volume":"7","author":"Ammons","year":"2023","journal-title":"Res Sq"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011091","article-title":"Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma","volume":"13","author":"Chen","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1680554","article-title":"Integrated multi-omics reveals GABARAP-mediated mitophagy and pyruvate metabolism as key drivers of osteosarcoma progression","volume":"16","author":"Han","year":"2025","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.11.002","article-title":"Genetic immune escape in cancer: timing and implications for treatment","volume":"11","author":"Mart\u00ednez-Jim\u00e9nez","year":"2025","journal-title":"Trends Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12935-023-03150-y","article-title":"Tumour cells can escape antiproliferative pressure by interferon-\u03b2 through immunoediting of interferon receptor expression","volume":"23","author":"Hiebinger","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class I antigen presentation","volume":"12","author":"DhatChinamoorthy","year":"2021","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41392-025-02521-3","article-title":"When vaccines reset tumors: SARS-CoV-2 mRNA shots create a transient checkpoint-sensitive state","volume":"10","author":"Chi","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.907550","article-title":"Immune microenvironment in osteosarcoma: components, therapeutic strategies and clinical applications","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1362970","article-title":"Single-cell RNA-seq reveals T cell exhaustion and immune response landscape in osteosarcoma","volume":"15","author":"Fan","year":"2024","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2019.07.017","article-title":"Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression","volume":"65","author":"Saleh","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1689790","article-title":"Osteosarcoma immunometabolism: emerging mechanisms and clinical implications","volume":"16","author":"Tan","year":"2025","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcancer.2017.02.010","article-title":"The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells","volume":"45","author":"Ramachandran","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1072","DOI":"10.1002\/ctm2.1072","article-title":"Characterization of the tumour microenvironment phenotypes in Malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients","volume":"12","author":"Zhang","year":"2022","journal-title":"Clin Transl Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.976990","article-title":"Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma","volume":"13","author":"Huang","year":"2022","journal-title":"Front Genet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41698-023-00415-7","article-title":"Comprehensive analysis of angiogenesis pattern and related immune landscape for individual treatment in osteosarcoma","volume":"7","author":"Liao","year":"2023","journal-title":"NPJ Precis Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.32604\/or.2024.056860","article-title":"Targeting myeloid-derived suppressor cells in the tumor microenvironment: potential therapeutic approaches for osteosarcoma","volume":"33","author":"Ka","year":"2025","journal-title":"Oncol Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1728091","article-title":"Epigenetic control of antigen presentation failure in osteosarcoma: from single-cell chromatin maps to therapeutic strategies","volume":"16","author":"He","year":"2025","journal-title":"Front Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152383","article-title":"Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer","volume":"132","author":"Demel","year":"2022","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153167","article-title":"Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-\u03b3-stimulated antitumor immunity","volume":"132","author":"Ren","year":"2022","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","article-title":"An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer","volume":"36","author":"Burr","year":"2019","journal-title":"Cancer Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1584450","article-title":"Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e2400538","DOI":"10.1002\/adhm.202400538","article-title":"Enhanced osteosarcoma immunotherapy via caCO(3) nanoparticles: remodeling tumor acidic and immune microenvironment for photodynamic therapy","volume":"13","author":"Gao","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1350187","article-title":"Hypoxia inducible factor-1\u03b1 as a potential therapeutic target for osteosarcoma metastasis","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Pharmacol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"83","DOI":"10.31083\/j.fbl2902083","article-title":"Metabolic landscape of osteosarcoma: reprogramming of lactic acid metabolism and metabolic communication","volume":"29","author":"Wang","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2023.63","article-title":"Unlocking antitumor immunity with adenosine receptor blockers","volume":"6","author":"Remley","year":"2023","journal-title":"Cancer Drug Resist"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1518664","article-title":"NF-\u03baB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance","volume":"16","author":"Shi","year":"2025","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"114260","DOI":"10.1016\/j.intimp.2025.114260","article-title":"The origin and polarization of Macrophages and their role in the formation of the Pre-Metastatic niche in osteosarcoma","volume":"150","author":"Lai","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6595252","DOI":"10.1155\/2024\/6595252","article-title":"Develop a novel signature to predict the survival and affect the immune microenvironment of osteosarcoma patients: anoikis-related genes","volume":"2024","author":"Yang","year":"2024","journal-title":"J Immunol Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"102122","DOI":"10.1016\/j.labinv.2024.102122","article-title":"Intratumoral heterogeneity assessment of the extracellular bone matrix and immune microenvironment in osteosarcoma using digital imaging to predict therapeutic response","volume":"104","author":"Gomez-Mascard","year":"2024","journal-title":"Lab Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41413-024-00359-z","article-title":"Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma","volume":"12","author":"Lacinski","year":"2024","journal-title":"Bone Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20151","article-title":"Evaluation of P-glycoprotein, HER-2\/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma","volume":"100","author":"Ferrari","year":"2004","journal-title":"Cancer"},{"key":"B69","doi-asserted-by":"publisher","first-page":"102143","DOI":"10.1016\/j.labinv.2024.102143","article-title":"Spatial heterogeneity of PD-1\/PD-L1 defined osteosarcoma microenvironments at single-cell spatial resolution","volume":"104","author":"Yang","year":"2024","journal-title":"Lab Invest"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1579822","article-title":"Emerging immunotherapies in osteosarcoma: from checkpoint blockade to cellular therapies","volume":"16","author":"Han","year":"2025","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"6563609","DOI":"10.1155\/2023\/6563609","article-title":"The prognostic model established by the differential expression genes based on CD8(+) T cells to evaluate the prognosis and the response to immunotherapy in osteosarcoma","volume":"2023","author":"Chen","year":"2023","journal-title":"Mediators Inflammation"},{"key":"B72","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41698-025-00896-8","article-title":"Single-cell and spatial transcriptomics reveals the key role of MCAM(+) tip-like endothelial cells in osteosarcoma metastasis","volume":"9","author":"Tang","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"0530","DOI":"10.34133\/research.0530","article-title":"Single-cell spatial-temporal analysis of ZNF451 in mediating drug resistance and CD8(+) T cell dysfunction","volume":"7","author":"Tang","year":"2024","journal-title":"Res (Wash D C)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-018-0560-1","article-title":"PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse","volume":"11","author":"Zheng","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e008589","DOI":"10.1136\/jitc-2023-008589","article-title":"Spatially resolved tissue imaging to analyze the tumor immune microenvironment: beyond cell-type densities","volume":"12","author":"Lopez Janeiro","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1177\/15353702221142607","article-title":"Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8(+)\u2009T cells in osteosarcoma","volume":"248","author":"Xie","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1394339","article-title":"Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies","volume":"12","author":"Liang","year":"2024","journal-title":"Front Cell Dev Biol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1802194\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:03:44Z","timestamp":1774368224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1802194\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":77,"alternative-id":["10.3389\/fimmu.2026.1802194"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1802194","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"1802194"}}